Skip to content
  • Saturday, 12 September 2026
  • 5:53 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Pharmaceutical R&D

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation

Teuku Ryan Jul 25, 2026 0

Sanofi has announced a significant strategic decision to halt the development and forgo filing for approval of its immunology therapy,…

Read More
Data Science & Bioinformatics

Developer Chronicles Journey of Building Bespoke AI Assistant, Citing Enhanced Productivity and Data Sovereignty

Evan Lee Salim Jun 17, 2026 0

The burgeoning landscape of artificial intelligence continues to reshape professional workflows, but for one software engineer, the generic offerings fell…

Read More
Laboratory Automation & Robotics

FDA Commissioner Marty Makary Resigns Amid Pressure from Administration, Citing Policy Conflicts and Agency Instability

Lana Keisha Jun 3, 2026 0

Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, amidst a period of intense…

Read More
Pharmaceutical R&D

Wes Streeting Resigns as UK Health Secretary Citing Loss of Faith in Labour Leadership Following Local Election Debacle

Teuku Ryan May 15, 2026 0

The political landscape of the United Kingdom has been significantly reshaped by the dramatic resignation of Wes Streeting, the UK…

Read More
Laboratory Automation & Robotics

FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts

Lana Keisha Apr 6, 2026 0

Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…

Read More
Laboratory Automation & Robotics

FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design

Lana Keisha Mar 28, 2026 0

Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…

Read More
Duke-NUS Researchers Discover Molecular Switch Regulating Muscle Regeneration and Sarcopenia5 Key Concepts Behind Agentic AI Every Engineer Must UnderstandTop pharma companies set sustainability goals, but emissions are still increasingPharmSci 360 2026 heads to New Orleans this October
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ